A Study of ZL-1310 in Participants With Selected Solid Tumors

Part of paid clinical trials in San Francisco, California.

Sponsor
Zai Lab (Shanghai) Co., Ltd.
Study ID
NCT06885281
Phase
PHASE1/PHASE2
Status
Recruiting
Apply to this trial

Conditions

  • Solid Tumors

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

A Phase 1b/2, Open-label, Multi-center Study of ZL-1310 in Participants With Selected Solid Tumors

Key Dates

Start date
May 12, 2025
Status verified
Mar 2026
Primary completion
Aug 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
112 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Single Arm
    ZL-1310 as a single agent

Primary Outcome Measure

Incidence of Treatment Emergent Adverse-Events in Phase 1b [ Time Frame: up to 31 months ]

Central Contacts

Locations (12)

FacilityCityStateZIPSite coordinators
Zai Lab Site 2001San FranciscoCalifornia94143
Site 2001
Zai Lab Site 2015PeoriaIllinois61637
Site 2015
Zai Lab Site 2013DetroitMichigan48201
Site 2013
Zai Lab Site 2002New YorkNew York10065
Site 2002
Zai Lab Site 2024ClevelandOhio44106
Site 2024
Zai Lab Site 2004PhiladelphiaPennsylvania19111
Site 2004
Zai Lab Site 2014NashvilleTennessee37203
Site 2014
Zai Lab Site 2003DallasTexas75246
Site 2003
Zai Lab Site 2007HoustonTexas77030
Site 2007
Zai Lab Site 2011McAllenTexas78503
Site 2011
Zai Lab Site 2006FairfaxVirginia22031
Site 2006
Zai Lab Site 2012NorfolkVirginia23502
Site 2012

Find similar trials in San Francisco, CA

By research site
Zai Lab· San Francisco, CAZai Lab· Peoria, ILZai Lab· Detroit, MIZai Lab· New York, NYZai Lab· Cleveland, OHZai Lab· Philadelphia, PA

Related Studies